The incidence of FGFRi-associated nail toxicities varies by agent and can affect quality of life and treatment adherence. The pathogenesis remains unclear, and no predictive biomarkers exist. Further research into optimized management and preventative strategies is needed. Early recognition and proactive multidisciplinary management are essential to minimizing complications and maintaining oncologic treatment continuity. .
Building similarity graph...
Analyzing shared references across papers
Loading...
Aneri Bhargav Patel
Xiying Fan
Janellen Smith
Journal of Drugs in Dermatology
Building similarity graph...
Analyzing shared references across papers
Loading...
Patel et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69abc0b85af8044f7a4e95b5 — DOI: https://doi.org/10.36849/jdd.9496
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: